Cargando…
A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action
CK2 is a ubiquitous protein kinase with an anti-apoptotic role and is found to be overexpressed in multiple cancer types. To this end, the inhibition of CK2 is of great interest with regard to the development of novel anti-cancer therapeutics. ATP-site inhibition of CK2 is possible; however, this ty...
Autores principales: | Brear, Paul, De Fusco, Claudia, Atkinson, Eleanor L., Iegre, Jessica, Francis-Newton, Nicola J., Venkitaraman, Ashok R., Hyvönen, Marko, Spring, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667777/ https://www.ncbi.nlm.nih.gov/pubmed/36426237 http://dx.doi.org/10.1039/d2md00161f |
Ejemplares similares
-
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
por: De Fusco, Claudia, et al.
Publicado: (2017) -
Development of small cyclic peptides targeting the CK2α/β interface
por: Atkinson, Eleanor L., et al.
Publicado: (2022) -
Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study
por: Atkinson, Eleanor L., et al.
Publicado: (2021) -
Specific inhibition of CK2α from an anchor outside the active site
por: Brear, Paul, et al.
Publicado: (2016) -
Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein–protein interaction
por: Iegre, Jessica, et al.
Publicado: (2019)